Kowaluk A, Malicka I, Kalwak K, Wozniewski M
Cancers (Basel). 2024; 16(21).
PMID: 39518038
PMC: 11545673.
DOI: 10.3390/cancers16213599.
Mackie D, Kuo D, Paul M, Elster J
Cureus. 2023; 15(3):e36712.
PMID: 37113346
PMC: 10129031.
DOI: 10.7759/cureus.36712.
Offenbacher R, Gorlick J, Weiser D
Cancer Rep (Hoboken). 2022; 5(11):e1724.
PMID: 36199156
PMC: 9675379.
DOI: 10.1002/cnr2.1724.
Todurkar N, Trehan A, Bansal D
Indian J Med Res. 2022; 154(4):615-622.
PMID: 35435347
PMC: 9204995.
DOI: 10.4103/ijmr.IJMR_2483_19.
Lima M, de Sa Rodrigues K, Vanucci M, da Silva P, Baeta T, Oliveira I
Hematol Transfus Cell Ther. 2021; 45(2):170-175.
PMID: 34866034
PMC: 10244251.
DOI: 10.1016/j.htct.2021.08.005.
Impact of respiratory viral panel testing on length of stay in pediatric cancer patients admitted with fever and neutropenia.
Shinn K, Wetzel M, DeGroote N, Keller F, Briones M, Felker J
Pediatr Blood Cancer. 2020; 67(11):e28570.
PMID: 32881268
PMC: 7721999.
DOI: 10.1002/pbc.28570.
Evaluation of risk stratification strategies in pediatric patients with febrile neutropenia.
Janssens K, Sobrinho Valete C, Araujo da Silva A, Ferman S
J Pediatr (Rio J). 2020; 97(3):302-308.
PMID: 32505617
PMC: 9432306.
DOI: 10.1016/j.jped.2020.05.002.
Outpatient treatment for people with cancer who develop a low-risk febrile neutropaenic event.
Rivas-Ruiz R, Villasis-Keever M, Miranda-Novales G, Castelan-Martinez O, Rivas-Contreras S
Cochrane Database Syst Rev. 2019; 3:CD009031.
PMID: 30887505
PMC: 6423292.
DOI: 10.1002/14651858.CD009031.pub2.
Simple predictors of the re- occurrence of severe febrile neutropenia episode: a single-center retrospective cohort study in pediatric patients with malignant diseases.
Segulja S, Ruzic A, Dujmic D, Bazdaric K, Roganovic J
Croat Med J. 2019; 60(1):20-25.
PMID: 30825274
PMC: 6406065.
Predictive value of PCT and IL-6 for bacterial infection in children with cancer and febrile neutropenia.
van der Galien H, Loeffen E, Miedema K, Tissing W
Support Care Cancer. 2018; 26(11):3819-3826.
PMID: 29777383
PMC: 6182367.
DOI: 10.1007/s00520-018-4249-3.
Evaluation of a fever-management algorithm in a pediatric cancer center in a low-resource setting.
Mukkada S, Smith C, Aguilar D, Sykes A, Tang L, Dolendo M
Pediatr Blood Cancer. 2017; 65(2).
PMID: 28895277
PMC: 6051353.
DOI: 10.1002/pbc.26790.
Can complications in febrile neutropenia be predicted? Report from a developing country.
Oberoi S, Das A, Trehan A, Ray P, Bansal D
Support Care Cancer. 2017; 25(11):3523-3528.
PMID: 28601903
DOI: 10.1007/s00520-017-3776-7.
Efficacy and safety of withholding antimicrobial treatment in children with cancer, fever and neutropenia, with a demonstrated viral respiratory infection: a randomized clinical trial.
Santolaya M, Alvarez A, Acuna M, Aviles C, Salgado C, Tordecilla J
Clin Microbiol Infect. 2016; 23(3):173-178.
PMID: 27856269
PMC: 7129180.
DOI: 10.1016/j.cmi.2016.11.001.
Very early discharge versus early discharge versus non-early discharge in children with cancer and febrile neutropenia.
Loeffen E, Te Poele E, Tissing W, Boezen H, de Bont E
Cochrane Database Syst Rev. 2016; 2:CD008382.
PMID: 26899263
PMC: 10372717.
DOI: 10.1002/14651858.CD008382.pub2.
Bacterial bloodstream infections and antimicrobial susceptibility pattern in pediatric hematology/oncology patients after anticancer chemotherapy.
Al-Mulla N, Taj-Aldeen S, El Shafie S, Janahi M, Al-Nasser A, Chandra P
Infect Drug Resist. 2014; 7:289-99.
PMID: 25395866
PMC: 4226521.
DOI: 10.2147/IDR.S70486.
Development and validation of a prediction model for diagnosing blood stream infections in febrile, non-neutropenic children with cancer.
Esbenshade A, Di Pentima M, Zhao Z, Shintani A, Esbenshade J, Simpson M
Pediatr Blood Cancer. 2014; 62(2):262-268.
PMID: 25327666
PMC: 4402108.
DOI: 10.1002/pbc.25275.
Antibacterial effect of autologous platelet-rich gel derived from subjects with diabetic dermal ulcers in vitro.
Chen L, Wang C, Liu H, Liu G, Ran X
J Diabetes Res. 2013; 2013:269527.
PMID: 23671863
PMC: 3647554.
DOI: 10.1155/2013/269527.
Updated systematic review and meta-analysis of the performance of risk prediction rules in children and young people with febrile neutropenia.
Phillips R, Lehrnbecher T, Alexander S, Sung L
PLoS One. 2012; 7(5):e38300.
PMID: 22693615
PMC: 3365042.
DOI: 10.1371/journal.pone.0038300.
Predicting infectious complications in neutropenic children and young people with cancer (IPD protocol).
Phillips R, Sutton A, Riley R, Chisholm J, Picton S, Stewart L
Syst Rev. 2012; 1:8.
PMID: 22588015
PMC: 3351734.
DOI: 10.1186/2046-4053-1-8.
Outpatient management of febrile neutropenia in children with cancer.
Ziino O, Tucci F, Rossi M
Pediatr Rep. 2011; 3(1):e8.
PMID: 21647281
PMC: 3103131.
DOI: 10.4081/pr.2011.e8.